Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?
Pharmacol Res
; 156: 104791, 2020 06.
Article
in En
| MEDLINE
| ID: mdl-32302707
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Interleukin-17
/
Betacoronavirus
Limits:
Humans
Language:
En
Journal:
Pharmacol Res
Journal subject:
FARMACOLOGIA
Year:
2020
Type:
Article
Affiliation country:
Italy